Your browser doesn't support javascript.
loading
The impact of tertiary lymphoid structures on clinicopathological, genetic and gene expression characteristics in lung adenocarcinoma.
Tamiya, Yutaro; Nakai, Tokiko; Suzuki, Ayako; Mimaki, Sachiyo; Tsuchihara, Katsuya; Sato, Kei; Yoh, Kiyotaka; Matsumoto, Shingo; Zenke, Yoshitaka; Nosaki, Kaname; Izumi, Hiroki; Shibata, Yuji; Sakai, Tetsuya; Taki, Tetsuro; Miyazaki, Saori; Watanabe, Reiko; Sakamoto, Naoya; Sakashita, Shingo; Kojima, Motohiro; Hashimoto, Naozumi; Tsuboi, Masahiro; Goto, Koichi; Ishii, Genichiro.
Affiliation
  • Tamiya Y; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Nakai T; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.
  • Suzuki A; Department of Computational Biology and Medical Sciences, The University of Tokyo, Kashiwa, Japan.
  • Mimaki S; Division of Translational Informatics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
  • Tsuchihara K; Division of Translational Informatics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
  • Sato K; Department of Thoracic Surgery, National Cancer Center Hospital East, Kashiwa, Japan.
  • Yoh K; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Matsumoto S; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Zenke Y; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Nosaki K; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Izumi H; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Shibata Y; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Sakai T; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Taki T; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.
  • Miyazaki S; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.
  • Watanabe R; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.
  • Sakamoto N; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan; Division of Innovative Pathology and Laboratory Medicine, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
  • Sakashita S; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan; Division of Innovative Pathology and Laboratory Medicine, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
  • Kojima M; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan; Division of Innovative Pathology and Laboratory Medicine, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
  • Hashimoto N; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Tsuboi M; Department of Thoracic Surgery, National Cancer Center Hospital East, Kashiwa, Japan.
  • Goto K; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Ishii G; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan; Division of Innovative Pathology and Laboratory Medicine, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan. Electronic address: gishii@east.ncc.go.j
Lung Cancer ; 174: 125-132, 2022 Dec.
Article in En | MEDLINE | ID: mdl-36379125

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tertiary Lymphoid Structures / Adenocarcinoma of Lung / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Lung Cancer Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Japan Country of publication: Ireland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tertiary Lymphoid Structures / Adenocarcinoma of Lung / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Lung Cancer Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Japan Country of publication: Ireland